BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3987283)

  • 21. [Erythropoietin].
    Mori H; Hiraoka K; Fujita Y
    Nihon Rinsho; 1991 Dec; 49 Suppl():170-4. PubMed ID: 1808250
    [No Abstract]   [Full Text] [Related]  

  • 22. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluid removal with negative-pressure hydrostatic ultrafiltration using a partial vacuum.
    Ing TS; Ashbach DL; Kanter A; Oyama JH; Armbruster KF; Merkel FK
    Nephron; 1975; 14(6):451-5. PubMed ID: 239356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of graded poly vinyl alcohol membranes.
    Odian M; Leonard EF
    Trans Am Soc Artif Intern Organs; 1968; 14():19-24. PubMed ID: 5701530
    [No Abstract]   [Full Text] [Related]  

  • 25. ASAHI hollow fiber kidney (ASAHI HFK) --- progress report.
    Maeda K; Ota K; Saito A; Shimoji T; Amano I
    Trans Am Soc Artif Intern Organs; 1974; 20A():344-52. PubMed ID: 4450356
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemodiafiltration--an avenue to shorter dialysis?
    Wizemann V
    Contrib Nephrol; 1985; 44():49-56. PubMed ID: 3987292
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term results of dialysis therapy with a highly permeable membrane.
    Chanard J; Brunois JP; Melin JP; Lavaud S; Toupance O
    Artif Organs; 1982 Aug; 6(3):261-6. PubMed ID: 6817736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The decline in serum albumin after conversion to high flux, high efficiency dialysis.
    Kirschbaum B
    Artif Organs; 1994 Oct; 18(10):729-35. PubMed ID: 7832653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes.
    Woffindin C; Hoenich NA
    Biomaterials; 1988 Jan; 9(1):53-7. PubMed ID: 3126842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technical and clinical evaluation of a new synthetic low flux polysulphon membrane for hemodialysis.
    Ronco C; Fabris A; Feriani M; Chiaramonte S; Brendolan A; Emiliani G; La Greca G
    Int J Artif Organs; 1989 Jul; 12(7):450-60. PubMed ID: 2670778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C
    Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract]   [Full Text] [Related]  

  • 33. Granulocyte adherence changes during hemodialysis.
    Aljama P; Martin-Malo A; Pérez R; Castillo D; Torres A; Velasco F
    Contrib Nephrol; 1985; 46():75-82. PubMed ID: 4006481
    [No Abstract]   [Full Text] [Related]  

  • 34. Solute clearance in continuous venovenous hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone membranes.
    Ifediora OC; Teehan BP; Sigler MH
    ASAIO J; 1992; 38(3):M697-701. PubMed ID: 1457952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Beta 2-microglobulin kinetics during hemodialysis with different membranes].
    Stetsiuk EA; Siniukhin VN; Danilkov AP; Shpazhnikova NS; Nikolaeva NP; Khamaganova EG
    Urol Nefrol (Mosk); 1995; (3):18-20. PubMed ID: 7618215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

  • 37. Phagocytic activity of leukocytes induced by different dialyzer membranes.
    Vanholder R; Dhondt A; Van Landschoot N; Waterloos MA; Ringoir S
    Contrib Nephrol; 1989; 74():86-90. PubMed ID: 2518453
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimized cellulose membranes for artificial kidney dialysis applications.
    Meltzer TH; Gutfreund K; Kulshrestha VK; Stake AM
    Trans Am Soc Artif Intern Organs; 1968; 14():12-8. PubMed ID: 5701524
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adsorption characteristics of the synthetic polymer dialysis membranes].
    Tajima N; Kanda H; Tikugo K; Kuriyama S
    Nihon Rinsho; 2004 May; 62 Suppl 5():78-82. PubMed ID: 15197891
    [No Abstract]   [Full Text] [Related]  

  • 40. Leucocyte occlusion of cuprophane membranes as a cause of reduced hemodialysis efficiency.
    Dodd NJ; Parsons V; Weston MJ
    Int J Artif Organs; 1982 Jul; 5(4):275-6. PubMed ID: 7118290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.